Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FUROSEMIDE Cause Chronic kidney disease? 439 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 439 reports of Chronic kidney disease have been filed in association with FUROSEMIDE (Furosemide). This represents 0.9% of all adverse event reports for FUROSEMIDE.

439
Reports of Chronic kidney disease with FUROSEMIDE
0.9%
of all FUROSEMIDE reports
33
Deaths
330
Hospitalizations

How Dangerous Is Chronic kidney disease From FUROSEMIDE?

Of the 439 reports, 33 (7.5%) resulted in death, 330 (75.2%) required hospitalization, and 14 (3.2%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE. However, 439 reports have been filed with the FAERS database.

What Other Side Effects Does FUROSEMIDE Cause?

Acute kidney injury (7,984) Hypotension (4,468) Dyspnoea (3,559) Fall (3,410) Drug ineffective (3,297) Hyponatraemia (3,127) Hypokalaemia (2,503) Dehydration (2,195) Off label use (2,147) Fatigue (2,107)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which FUROSEMIDE Alternatives Have Lower Chronic kidney disease Risk?

FUROSEMIDE vs FUROSEMIDE\SPIRONOLACTONE FUROSEMIDE vs FUSIDATE FUROSEMIDE vs FUSIDIC ACID FUROSEMIDE vs FUTIBATINIB FUROSEMIDE vs GABAPENTIN

Related Pages

FUROSEMIDE Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease FUROSEMIDE Demographics